Altered cathepsin D metabolism in PHEX antisense human osteoblast cells

Biochemical and Biophysical Research Communications

Volumn 332, Issue 1, 2005, Pages 248-253

  Matsumoto, Naoko ^a   Jo, Oak D ^a   Shih, Remi N J ^a   Yanagawa, Norimoto ^a  

^a NONE

Author keywords

Bone; Cathepsin D; Hypophosphatemia; Osteoblast cell; Pepstatin; Rickets

Indexed keywords

CATHEPSIN D; MINHIBIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BONE MINERALIZATION; CELL CULTURE; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME METABOLISM; GENE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOPHOSPHATEMIA; OSTEOBLAST; PHEX GENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; RICKETS;

CALCIFICATION, PHYSIOLOGIC; CALCIUM; CATHEPSIN D; CELL LINE; DNA, ANTISENSE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; OSTEOBLASTS; PHEX PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; PROTEINS;

EID: 19344367077     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.116     Document Type: Article

References (16)

1. H.S. Tenenhouse X-linked hypophosphataemia: a homologous disorder in humans and mice Nephrol. Dial. Transplant. 14 1999 333 341
2. L.D. Quarles FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization Am. J. Physiol. Endocrinol. Metab. 285 2003 E1 E9
3. N.R. Shih, O.D. Jo, and N. Yanagawa Effects of PHEX antisense in human osteoblast cells J. Am. Soc. Nephrol. 13 2002 394 399
4. H.C. Blair How the osteoclast degrades bone Bioessays 20 1998 837 846
5. G. Berchem, M. Glondu, M. Gleizes, J.P. Brouillet, F. Vignon, M. Garcia, and E. Liaudet-Coopman Cathepsin D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis Oncogene 21 2002 5951 5955
6. H. Rochefort, and E. Liaudet-Coopman Cathepsin D in cancer metastasis: a protease and a ligand Acta Pathol. Microbiol. Immunol. Scand. Suppl. 107 1999 86 95
7. T. Tsukuba, K. Okamoto, Y. Yasuda, W. Morikawa, H. Nakanishi, and K. Yamamoto New functional aspects of cathepsin D and cathepsin E Mol. Cells 10 2000 601 611
8. P.S. Rowe, P.A. de Zoysa, R. Dong, H.R. Wang, K.E. White, M.J. Econs, and C.L. Oudet MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia Genomics 67 2000 54 68
9. T. Berndt, T.A. Craig, A.E. Bowe, J. Vassiliadis, D. Reczek, R. Finnegan, S.M. Jan De Beur, S.C. Schiavi, and R. Kumar Secreted frizzled-related protein4 is a potent tumor-derived phosphaturic agent J. Clin. Invest. 112 2003 785 794
10. P.S. Rowe, Y. Kumagai, G. Gutierrez, I.R. Garrett, R. Blacher, D. Rosen, J. Cundy, S. Navvab, D. Chen, M.K. Drezner, L.D. Quarles, and G.R. Mundy MEPE has the properties of an osteoblastic phosphatonin and minhibin Bone 34 2004 303 319
11. D. Bresler, J. Bruder, K.L. Mohnike, D. Fraser, and P.S.N. Rowe Serum MEPE-ASARM peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets J. Endocrinol. 183 2004 R1 R9
12. A. Jain, N.S. Fedarko, M.T. Collins, R. Gelman, M.A. Ankrom, M. Tayback, and L.W. Fisher Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density J. Clin. Endocrinol. Metab. 89 2004 4158 4161
13. P.S.N. Rowe, I.R. Garrett, P.M. Schwarz, D.L. Carnes, E.M. Lafer, G.R. Mundy, and G.E. Gutierrez Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP) Bone 36 2005 33 46
14. R. Guo, P.S. Rowe, S. Liu, L.G. Simpson, Z.S. Xiao, and L.D. Quarles Inhibition of MEPE cleavage by Phex Biochem. Biophys. Res. Commun. 297 2002 38 45
15. B. Lenarcic, J. Kos, I. Dolenc, P. Lucovnik, I. Krizaj, and V. Turk Cathepsin D inactivates cysteine proteinase inhibitors, cystatins Biochem. Biophys. Res. Commun. 154 1998 765 772
16. Y. Nishimura, T. Kawabata, and K. Kato Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro Arch. Biochem. Biophys. 261 1998 64 71